Metastatic Malignant Small Intestinal Neoplasm: Clinical Trials

1 trial for Metastatic Malignant Small Intestinal Neoplasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Active not recruiting 1

Follow Metastatic Malignant Small Intestinal Neoplasm: new trials by email Literature Review of Metastatic Malignant Small Intestinal Neoplasm trials Research Report on Metastatic Malignant Small Intestinal Neoplasm

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events
Best Practice, Patient Monitoring, Questionnaire Administration - Clinical Stage IV Esophageal Adenocarcinoma AJCC v8, Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8
Not applicableActive not recruitingM.D. Anderson Cancer Center7502021-05-122026-06-16

Narrower conditions

Carcinoma, Hepatocellular (1)  ·  Colonic Neoplasms (1)  ·  Esophageal Neoplasms (1)  ·  Gastrointestinal Neoplasms (1)  ·  Pancreatic Neoplasms (1)  ·  Rectal Neoplasms (1)  ·  Stomach Neoplasms (1)

Broader conditions

Adenocarcinoma (1)  ·  Carcinoma (1)  ·  Colonic Diseases (1)  ·  Colorectal Neoplasms (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Esophageal Diseases (1)  ·  Gastrointestinal Diseases (1)  ·  Head and Neck Neoplasms (1)  ·  Intestinal Diseases (1)  ·  Intestinal Neoplasms (1)  ·  Liver Diseases (1)  ·  Liver Neoplasms (1)

Interventions

Practice Guidelines as Topic (1)  ·  Remote Patient Monitoring (1)  ·  Standard of Care (1)

Sponsors

M.D. Anderson Cancer Center (1)

Countries

United States (1)

Top investigators

Ryan W Huey, MD (1)

Results publications

PMID 36821818